Viewing nowApito Tablet 40 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.

MFDS item code 202002309 · Approved 2020.04.02 · Insurance code 662505000
Improvement of hyperlipidemia; prevention of cardiovascular diseases (including myocardial infarction and stroke)
This medication helps to reduce various risk factors associated with cardiovascular disease. In particular, it decreases the risk of myocardial infarction and stroke in adults who have risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, in cases where coronary heart disease already exists, this medication lowers the risks of non-fatal myocardial infarction and stroke, the need for vascular interventions, hospitalization due to congestive heart failure, and the occurrence of angina. It is also effective in the treatment of hyperlipidemia and is used to decrease total cholesterol and LDL-cholesterol while increasing HDL-cholesterol in patients with various types of dyslipidemia. It is especially useful when dietary control is difficult or when used in combination with other therapies. This medication is used to improve cardiovascular health and reduce risk factors.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. It may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, in patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dosage adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
This medication may cause muscle-related symptoms, so if muscle pain or weakness occurs, consult a physician immediately. In particular, if there is a significant increase in muscle enzyme levels or if myopathy is suspected, the medication should be discontinued. This medication may affect liver function, so patients with liver disease or elevated liver enzyme levels should not take it. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medication, and females of childbearing age should use appropriate contraception during treatment. Children under 10 years of age and patients with certain genetic lactose metabolism disorders should also not take this medication. Those with a history of alcohol abuse, liver disease, impaired kidney function, and the elderly should use this medication with caution and should closely monitor for the risk of myopathy. This medication has many drug interactions, so it is advisable to consult a doctor or pharmacist, especially when taking certain antibiotics, antifungals, HIV treatments, and other lipid-lowering agents. Regular liver function tests and muscle enzyme tests should be conducted during treatment, and any abnormal symptoms should be reported immediately. This medication may increase blood concentration when taken with grapefruit juice, so caution is required. There is no specific antidote for overdose; appropriate treatment should be given based on symptoms, and it should be kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it is best to store the medication at a cool room temperature, specifically between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.